Ibinsina Modern eye and retina center
Erbil, 44001, Iraq
NCT Number: NCT05269563
Double flapping technique to close the macular hole.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Erbil, 44001, Iraq
Recently, it is agreed to close the macular hole with the retinal innermost layer; which is called internal limiting membrane (ILM), in most cases, the hole closes. But, sometimes the ILM single flap might displace resulting in a persistent hole.
Therefore, the investigators tried to make two flaps utilizing ILM, and sometimes certain patients have a very thin membrane over the retina; it is called epiretinal membrane (ERM). The investigators use the double flapping technique by utilizing ERM; therefore, the ILM remains and can be used if the hole resists closing with the first surgical interventions.
Here, the investigators did not use any new materials with unknown side effects on the human retina. Although the flap technique is well known; however, investigators are making a double flap to decrease the chance of persisting macular holes.
The visual recovery will be appeared in the post-operative period, whether it is the same, better, or worse.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pars Plana Vitrectomy for Macular Hole Closure
Time frame: The fourth week post-operatively
The closure of the hole can be assessed clearly
Omer Othman Abdullah
Other
Double Flap Technique Utilizing ERM and ILM for Macular Hole
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06915948
Eye Diseases, Macular Holes
Palakkad, Kerala, India
View Trial DetailsNCT05860985
Epiretinal Membrane, Eye Diseases
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT06560710
Eye Diseases, Macular Holes
View Trial DetailsNCT06323902
Eye Diseases, Macular Hole of Left Eye (Disorder)
Pasto, Departamento de Nariño, Colombia
View Trial Details